News
TAIPEI, Taiwan I August 4, 2025 I Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New ...
HONG KONG, China I August 4, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its global, multicenter, randomized Phase II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback